This increased glucose availability stimulates CD27 expression on CD8+ T cells via mTOR-FOXM1 signaling, thereby enhancing cytotoxic T cell activity in immunocompetent and spontaneous HCC models. The gene discussed is MTOR; the disease is hepatocellular carcinoma.